STOK

MKT CAP:$2B

Stoke Therapeutics Inc

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$29.00-$1.90 (-6.15%)

Jun 8, 2026

52W High $38.3552W Low $11.13

Company Details

Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developi...

CEO

—

IPO Date

Jun 19, 2019

Website

www.stoketherapeutics.com

Key Metrics TTM

Revenue

$32M

-83.2% YoY

Net Income

-$170M

EPS (Diluted)

Free Cash Flow

-$148M

Revenue / Share

$0.51

Gross Margin

90.4%

Operating Margin

-577.5%

Net Margin

-529.2%

FCF Margin

-460.4%

P/S

59.2x

P/E

Earnings Reports

Q2 2026

Aug 11, 2026

PENDING

Q1 2026

May 7, 2026

$6M-96.1%

FY 2025

Mar 16, 2026

$184M+404.5%

Q4 2025

Mar 16, 2026

$1M-93.8%

Q3 2025

Nov 4, 2025

$11M+117.2%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee